These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1974283)
61. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089 [TBL] [Abstract][Full Text] [Related]
62. [Neuroleptic malignant syndrome--in need of acute care]. Poutanen O; Kiviniemi P Duodecim; 2004; 120(2):163-8. PubMed ID: 15065507 [No Abstract] [Full Text] [Related]
63. [Neuroleptic malignant syndrome after treatment with olanzapine]. Emborg C Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753 [TBL] [Abstract][Full Text] [Related]
64. [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics]. Staud L; Pflug B Psychiatr Prax; 1992 Jul; 19(4):114-8. PubMed ID: 1354879 [TBL] [Abstract][Full Text] [Related]
65. Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose. Korchia T; Blackman G; Cermolacce M; Richieri R BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30076161 [TBL] [Abstract][Full Text] [Related]
66. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine]. Krull F; Risse A Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787 [TBL] [Abstract][Full Text] [Related]
67. Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents. Spivak B; Gonen N; Mester R; Averbuch E; Adlersberg S; Weizman A Int Clin Psychopharmacol; 1996 Sep; 11(3):207-9. PubMed ID: 8923101 [TBL] [Abstract][Full Text] [Related]